Hematologic response to three alternative dosing schedules of azacitidine in patients with myelodysplastic syndromes.

Autor: Lyons RM, Cosgriff TM, Modi SS, Gersh RH, Hainsworth JD, Cohn AL, McIntyre HJ, Fernando IJ, Backstrom JT, Beach CL
Zdroj: Journal of Clinical Oncology; 4/10/2009, Vol. 27 Issue 11, p1850-1856, 7p
Databáze: Supplemental Index